Form 4 Tracker
Patel Gautam

Director · 1 filing · Latest: May 6, 2026

Amneal Pharmaceuticals, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
AMRX
Patel GautamDirectorMay 7, 2026
Option Exercise
34,8191,643,963
AMRX
Gautam PatelMay 2, 2025
Proposed Sale
$7.74160,000$1.2M
AMRX
Gautam J PatelJan 2, 2025
Proposed Sale
$8.00320,000$2.6M